Skip to main content
. 2017 May 30;24(9):2632–2638. doi: 10.1245/s10434-017-5897-0

Table 1.

Patient and tumor characteristics

Characteristics Results [N = 50]
Age at start of treatment, years [median (range)] 59 (35–75)
Male sex 27 (54)
Clinical tumor category
 T2N0 0 (0)
 T2N1 4 (8)
 T3N0 6 (12)
 T3N1-2 32 (64)
 T4N0 1 (2)
 T4N1-2 7 (14)
Metastatic site
 Liver 42 (84)
 Lung 5 (10)
 Lung and liver 3 (6)
Liver metastases
 1–3 36 (72)
 >3 9 (18)
Lung metastases
 1 5 (10)
 >1 3 (6)
Radiotherapy
 Patients completing radiotherapy 50 (100)
Interval between completion of RT and start of CT—days
 Median (range) 11 (3–44)
Chemotherapy
 Patients receiving six cycles 42 (84)
Surgery
 Radical surgical treatment 36 (72)
Sequence of surgery
 Simultaneous resection 25 (50.0)
 Primary first 10 (20)
 Metastases first 5 (10)

Data are expressed as n (%) unless otherwise specified

RT radiotherapy, CT chemotherapy